Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Bio-Rad Laboratories, Inc., a leading name in research and development services, is headquartered in the United States. Founded in 1952, the company has established itself as a key player in the life sciences and clinical diagnostics sectors. With a strong presence in North America, Europe, and Asia, Bio-Rad offers a diverse range of products and services, including reagents, instruments, and software for laboratories.
The company is renowned for its innovative solutions in areas such as genomics, proteomics, and quality control, setting it apart from competitors. Bio-Rad's commitment to advancing scientific discovery has earned it a prominent market position, with notable achievements in developing cutting-edge technologies that enhance research efficiency and accuracy.
+5 vs industry average
Bio Rad’s score of 38 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Bio-Rad, a US-based research and development services company, reported Scope 1 emissions of 15,167,000 kg CO2e and Scope 2 market-based emissions of 12,115,000 kg CO2e in 2024. For 2023, its Scope 1 emissions were 10,563,000 kg CO2e and Scope 2 market-based emissions were 13,920,000 kg CO2e. In 2022, Bio-Rad's Scope 1 emissions were 11,631,000 kg CO2e and Scope 2 market-based emissions were 14,029,000 kg CO2e. The company did not disclose Scope 3 emissions for 2024, 2023, or 2022, noting missing data points for categories such as purchased goods and services, business travel, and employee commute.
However, in 2019, Bio-Rad reported comprehensive emissions data, including Scope 1 emissions of 18,420,000 kg CO2e, Scope 2 market-based emissions of 13,615,000 kg CO2e, and Scope 3 emissions totalling 314,454,000 kg CO2e. Key Scope 3 categories for 2019 included purchased goods and services at 163,399,000 kg CO2e, downstream transportation and distribution at 74,424,000 kg CO2e, and use of sold products at 60,976,000 kg CO2e.
Bio-Rad has committed to reducing its Scope 1 and Scope 2 carbon emissions by 46.2% from a 2019 baseline by 2030.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more